Philip Hedge - Concepedia

Concepedia

Author

Philip Hedge

AstraZeneca (United Kingdom)

Also Known As

P J Hedge, P.J. Hedge, Philip Hedge, Philip J Hedge, Philip J. HEDGE, Philip J. Hedge

23

Publications

5.9K

Citations

16

H-Index

69

Concepts

All Affiliations

AstraZeneca (United Kingdom)University of Sussex The Cancer Institute Hospital MRC Protein Phosphorylation and Ubiquitylation Unit MRC Laboratory of Molecular Biology

PH

About

Philip Hedge is an author at AstraZeneca (United Kingdom) specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	5.8K
2	Natural Sciences	6	6	768
3	Biochemistry	6	6	649
4	Engineering	2	2	65
5	Health Sciences	2	2	135

Philip Hedge

×

17

Publications

5.9K

Citations

16

H-Index

	Year	Citations
Identification of FAP Locus Genes from Chromosome 5q21 Kenneth W. Kinzler, Mef Nilbert, Li-Kuo Su, Science Colorectal CancersCytogeneticsChromosome 5Q21GeneticsGenetic Disorder	1991	2.4K
Mutations of Chromosome 5q21 Genes in FAP and Colorectal Cancer Patients Isamu Nishisho, Yusuke Nakamura, Yasuo Miyoshi, Science OncologyChromosome 5Q21MedicineGeneticsGenetic Disorder	1991	1.9K
Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9 Brian G. Spratt, Philip Hedge, Stephan te Heesen, Gene Natural SciencesKanamycin-resistant VectorsMolecular BiologyGene VectorMicrobiology	1986	430
Paradoxical activation of Raf by a novel Raf inhibitor Clare A Hall-Jackson, Patrick A. Eyers, Philip P. Cohen, Chemistry & Biology BiochemistryMedicineNovel Raf InhibitorMechanism Of ActionPharmacotherapy	1999	261
The DCC Gene: Structural Analysis and Mutations in Colorectal Carcinomas Kathleen R. Cho, Jonathan D. Oliner, Jonathan W. Simons, Genomics Tumor BiologyDcc Gene AlterationsOncologyDcc ExonsOncogenic Agent	1994	223
Regulation of apoptosis by BH3 domains in a cell-free system Sabina Cosulich, V Worrall, Philip Hedge, Current Biology Signal TransductionSignaling PathwayCell RegulationApoptosisCell Death	1997	168
Effect of SB 203580 on the activity of c-Raf in vitro and in vivo Clare A Hall-Jackson, Michel Goedert, Philip Hedge, Oncogene Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1999	150
Structure of the human aldose reductase gene. Alexander Graham, L. Brown, Philip Hedge, Journal of Biological Chemistry BiosynthesisAldo-keto ReductaseCellular EnzymologyBiochemistryNatural Sciences	1991	79
Resistance to β-lactam antibiotics by re-modelling the active site of an E. coli penicillin-binding protein Philip Hedge, Brian G. Spratt Nature Antimicrobial Resistance GeneAntimicrobial Susceptibilityβ-Lactam AntibioticsBiochemistryAntibiotics	1985	70
Amino acid substitutions that reduce the affinity of penicillin‐binding protein 3 of <i>Escherichia coli</i> for cephalexin Philip Hedge, Brian G. Spratt European Journal of Biochemistry Klebsiella PneumoniaeMolecular BiologyEscherichia ColiAmino Acid SubstitutionsAntibiotic Resistance	1985	65

Page 1